• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参保的浸润性阴茎癌男性患者手术标准治疗未得到充分利用。

Underutilization of Surgical Standard of Care for Insured Men with Invasive Penile Cancer.

作者信息

Chang Edward K, Sekar Rishi R, Holt Sarah K, Gore John L, Wright Jonathan L, Nyame Yaw A

机构信息

Department of Urology, University of Washington School of Medicine, Seattle, Washington.

出版信息

Urol Pract. 2021 May 1;8(3):348-354. doi: 10.1097/UPJ.0000000000000214.

DOI:10.1097/UPJ.0000000000000214
PMID:33898656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8063966/
Abstract

PURPOSE

Prior studies of mixed insurance populations have demonstrated poor adherence to surgical standard of care (SOC) for penile cancer. We used data from the Surveillance, Epidemiology and End Results (SEER) cancer registry linked to Medicare to calculate SOC adherence to surgical treatment of penile cancer in insured men over the age of 65, focusing on potential social and racial disparities.

METHODS

This is an observational analysis of patients with T2-4 penile cancer of any histologic subtype without metastasis in the SEER-Medicare database (2004-2015). SOC was defined as penectomy (partial or radical) with bilateral inguinal lymph node dissection (ILND) based on the National Comprehensive Cancer Network guidelines. We calculated proportions of those receiving SOC and constructed multivariate models to identify factors associated with receiving SOC.

RESULTS

A total of 447 men were included. Of these men, 22.1% (99/447) received SOC while 18.8% (84/447) received no treatment at all. Only 23.3% (104/447) had ILND while 80.9% (362/447) underwent total or partial penectomy. Race and socioeconomic status (SES) were not associated with decreased SOC. Increasing age (OR 0.93, 95%CI:0.89-0.96), Charlson Comorbidity Index score ≥ 2 (OR 0.53, 95%CI:0.29-0.97), and T3-T4 disease (OR 0.34, 95%CI:0.18-0.65) were associated with not receiving SOC on adjusted analysis.

CONCLUSIONS

Rates of SOC are low among insured men 65 years of age or older with invasive penile cancer, regardless of race or SES. This finding is largely driven by low rates of ILND. Strategies are needed to overcome barriers to SOC treatment for men with invasive penile cancer.

摘要

目的

先前对混合保险人群的研究表明,阴茎癌患者对手术标准治疗(SOC)的依从性较差。我们利用与医疗保险相关的监测、流行病学和最终结果(SEER)癌症登记数据,计算65岁以上参保男性阴茎癌手术治疗的SOC依从性,重点关注潜在的社会和种族差异。

方法

这是一项对SEER - 医疗保险数据库(2004 - 2015年)中任何组织学亚型的T2 - 4期无转移阴茎癌患者的观察性分析。根据美国国立综合癌症网络指南,SOC定义为阴茎切除术(部分或根治性)加双侧腹股沟淋巴结清扫术(ILND)。我们计算了接受SOC治疗的患者比例,并构建多变量模型以识别与接受SOC治疗相关的因素。

结果

共纳入447名男性。其中,22.1%(99/447)接受了SOC治疗,而18.8%(84/447)根本未接受任何治疗。只有23.3%(104/447)进行了ILND,而80.9%(362/447)接受了全阴茎或部分阴茎切除术。种族和社会经济地位(SES)与SOC降低无关。调整分析显示,年龄增加(OR 0.93,95%CI:0.89 - 0.96)、Charlson合并症指数评分≥2(OR 0.53,95%CI:0.29 - 0.97)以及T3 - T4期疾病(OR 0.34,95%CI:0.18 - 0.65)与未接受SOC治疗相关。

结论

65岁及以上患有浸润性阴茎癌的参保男性中,SOC治疗率较低,无论种族或SES如何。这一发现主要是由ILND率低所致。需要采取策略来克服浸润性阴茎癌男性接受SOC治疗的障碍。

相似文献

1
Underutilization of Surgical Standard of Care for Insured Men with Invasive Penile Cancer.参保的浸润性阴茎癌男性患者手术标准治疗未得到充分利用。
Urol Pract. 2021 May 1;8(3):348-354. doi: 10.1097/UPJ.0000000000000214.
2
Management of the lymph nodes in penile cancer.阴茎癌的淋巴结管理。
Urology. 2010 Aug;76(2 Suppl 1):S43-57. doi: 10.1016/j.urology.2010.03.001.
3
The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma.腹股沟淋巴结清扫术在男性尿道鳞状细胞癌中的作用。
Urol Oncol. 2018 Dec;36(12):526.e1-526.e6. doi: 10.1016/j.urolonc.2018.09.014. Epub 2018 Nov 13.
4
Evaluation of dynamic sentinel lymph node biopsy in patients with squamous cell carcinoma of the penis and palpable inguinal nodes.阴茎鳞状细胞癌伴可触及腹股沟淋巴结患者的动态前哨淋巴结活检评估
BJU Int. 2008 Aug;102(3):305-9. doi: 10.1111/j.1464-410X.2008.07628.x. Epub 2008 Apr 11.
5
Volume-outcome relationship in penile cancer treatment: a population based patterns of care and outcomes study from Australia.阴茎癌治疗中的体积-结局关系:一项基于澳大利亚人群的治疗模式与结局研究。
BJU Int. 2016 Oct;118 Suppl 3:35-42. doi: 10.1111/bju.13626.
6
Chemotherapy Utilization in Men with Advanced Penile Cancer.晚期阴茎癌男性患者的化疗应用
Urol Pract. 2022 Jan;9(1):12-15. doi: 10.1097/UPJ.0000000000000270. Epub 2021 Oct 15.
7
Adherence to European Association of Urology and National Comprehensive Cancer Network Guidelines Criteria for Inguinal and Pelvic Lymph Node Dissection in Penile Cancer Patients-A Survey Assessment in German-speaking Countries on Behalf of the European Prospective Penile Cancer Study Group.遵循欧洲泌尿外科学会和国家综合癌症网络指南标准对阴茎癌患者进行腹股沟和盆腔淋巴结清扫术——以欧洲前瞻性阴茎癌研究组的名义在德语国家进行的调查评估。
Eur Urol Focus. 2021 Jul;7(4):843-849. doi: 10.1016/j.euf.2020.02.005. Epub 2020 Feb 20.
8
Single-Port Robotic Inguinal Lymph Node Dissection for Penile Cancer.单孔机器人腹股沟淋巴结清扫术治疗阴茎癌
Urology. 2022 Mar;161:153-156. doi: 10.1016/j.urology.2021.12.007. Epub 2021 Dec 20.
9
Positive lymphoscintigraphy (ILS) and negative computed tomography for metastatic penile cancer.转移性阴茎癌的淋巴管造影(ILS)结果为阳性而计算机断层扫描结果为阴性。
Hell J Nucl Med. 2011 Sep-Dec;14(3):309-10.
10
A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma.基于当代人群的阴茎癌淋巴结清扫率评估。
Ann Surg Oncol. 2011 Feb;18(2):439-46. doi: 10.1245/s10434-010-1315-6. Epub 2010 Sep 14.

引用本文的文献

1
Patterns of Treatment and Outcomes in Older Men With Penile Cancer: A SEER Dataset Analysis.老年阴茎癌男性的治疗模式与结局:一项监测、流行病学和最终结果(SEER)数据集分析
Front Oncol. 2022 Jun 29;12:926692. doi: 10.3389/fonc.2022.926692. eCollection 2022.

本文引用的文献

1
Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer.肌肉浸润性膀胱癌适当治疗的社会决定因素。
Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1339-1344. doi: 10.1158/1055-9965.EPI-18-1280. Epub 2019 May 15.
2
Adherence to the EAU guidelines on Penile Cancer Treatment: European, multicentre, retrospective study.遵守 EAU 阴茎癌治疗指南:一项欧洲多中心回顾性研究。
J Cancer Res Clin Oncol. 2019 Apr;145(4):921-926. doi: 10.1007/s00432-019-02864-9. Epub 2019 Mar 1.
3
Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study.遵循 EAU 阴茎癌指南可改善治疗结局:一项多中心国际研究。
World J Urol. 2019 Aug;37(8):1649-1657. doi: 10.1007/s00345-018-2549-3. Epub 2018 Oct 30.
4
Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis.淋巴结阳性阴茎癌患者的治疗趋势和结果。
JAMA Oncol. 2018 May 1;4(5):643-649. doi: 10.1001/jamaoncol.2017.5608.
5
Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysis.中高危临床局限性阴茎癌腹股沟淋巴结手术分期的应用及生存影响:一项倾向评分匹配分析
Urol Oncol. 2018 Apr;36(4):159.e7-159.e17. doi: 10.1016/j.urolonc.2017.12.001. Epub 2017 Dec 26.
6
Demographic and socioeconomic predictors of treatment delays, pathologic stage, and survival among patients with penile cancer: A report from the National Cancer Database.阴茎癌患者治疗延迟、病理分期及生存情况的人口统计学和社会经济预测因素:来自国家癌症数据库的报告
Urol Oncol. 2018 Jan;36(1):14.e17-14.e24. doi: 10.1016/j.urolonc.2017.09.014. Epub 2017 Oct 12.
7
Disparity between pre-existing management of penile cancer and NCCN guidelines.阴茎癌既往管理与美国国立综合癌症网络(NCCN)指南之间的差异。
Urol Oncol. 2017 Aug;35(8):531.e9-531.e14. doi: 10.1016/j.urolonc.2017.03.002. Epub 2017 Mar 28.
8
Disparities in Penile Cancer.阴茎癌的差异
Cancer Control. 2016 Oct;23(4):409-414. doi: 10.1177/107327481602300412.
9
15 Years of penile cancer management in the United States: An analysis of the use of partial penectomy for localized disease and chemotherapy in the metastatic setting.美国阴茎癌治疗15年:局部疾病行部分阴茎切除术及转移性疾病行化疗的应用分析
Urol Oncol. 2016 Dec;34(12):530.e1-530.e7. doi: 10.1016/j.urolonc.2016.06.019. Epub 2016 Aug 2.
10
Racial Disparities Differ for African Americans and Hispanics in the Diagnosis and Treatment of Penile Cancer.阴茎癌诊断与治疗中,非裔美国人和西班牙裔的种族差异有所不同。
Urology. 2016 Oct;96:22-28. doi: 10.1016/j.urology.2016.06.048. Epub 2016 Jul 9.